Enhanced bronchial expression of vascular endothelial growth factor and receptors (Flk-1 and Flt-1) in patients with chronic obstructive pulmonary disease.
about
From Here to There, Progenitor Cells and Stem Cells Are Everywhere in Lung Vascular RemodelingDirect isolation, culture and transplant of mouse skeletal muscle derived endothelial cells with angiogenic potential.Serum VEGF levels are related to the presence of pulmonary arterial hypertension in systemic sclerosis.Inflammatory changes in the airways of mice caused by cigarette smoke exposure are only partially reversed after smoking cessation.Vessel-associated transforming growth factor-beta1 (TGF-β1) is increased in the bronchial reticular basement membrane in COPD and normal smokersEpac1 and Epac2 are differentially involved in inflammatory and remodeling processes induced by cigarette smoke.Muscarinic receptor signaling in the pathophysiology of asthma and COPD.Serum levels of vascular endothelial growth factor in chronic obstructive pulmonary diseaseCigarette smoke and α,β-unsaturated aldehydes elicit VEGF release through the p38 MAPK pathway in human airway smooth muscle cells and lung fibroblasts.Variants in multiple genes polymorphism association analysis of COPD in the Chinese Li population.Therapeutic effects of LASSBio-596 in an elastase-induced mouse model of emphysemaProfiling serum biomarkers in patients with COPD: associations with clinical parametersVEGFR-2 inhibition augments cigarette smoke-induced oxidative stress and inflammatory responses leading to endothelial dysfunctionUpdate in chronic obstructive pulmonary disease 2005.Oxidative stress and the development of endothelial dysfunction in congenital heart disease with increased pulmonary blood flow: lessons from the neonatal lamb.Significance of wine and resveratrol in cardiovascular disease: French paradox revisitedAn investigation of the resolution of inflammation (catabasis) in COPD.Clinical implications for vascular endothelial growth factor in the lung: friend or foe?Molecular mechanisms in chronic obstructive pulmonary disease: potential targets for therapy.Increased expression of placenta growth factor in COPDAngiogenesis in chronic obstructive pulmonary disease: a translational appraisalFuture therapeutic treatment of COPD: struggle between oxidants and cytokinesPulmonary epithelium, cigarette smoke, and chronic obstructive pulmonary disease.Role of angiogenesis and vascular remodeling in chronic obstructive pulmonary disease.Multiple Circulating Cytokines Are Coelevated in Chronic Obstructive Pulmonary Disease.Cigarette smoke reversibly activates hypoxia-inducible factor 1 in a reactive oxygen species-dependent manner.Therapeutic perspectives in bronchial vascular remodeling in COPD.Resveratrol: a promising agent in promoting cardioprotection against coronary heart disease.Overexpression of farnesoid X receptor in small airways contributes to epithelial to mesenchymal transition and COX-2 expression in chronic obstructive pulmonary disease.The role of the bronchial microvasculature in the airway remodelling in asthma and COPD.Blood specimen biomarkers of inflammation, matrix degradation, angiogenesis, and cardiac involvement: a future useful tool in assessing clinical outcomes of COPD patients in clinical practice?Recent advances in understanding inflammation and remodeling in the airways in chronic obstructive pulmonary disease.Angiogenesis and vascular remodeling in chronic airway diseases.Why are kids with lupus at an increased risk of cardiovascular disease?Soluble CD200 Correlates With Interleukin-6 Levels in Sera of COPD Patients: Potential Implication of the CD200/CD200R Axis in the Disease Course.Role and regulation of VEGF and its receptors 1 and 2 in the aseptic loosening of total hip implants.Airway basal cell vascular endothelial growth factor-mediated cross-talk regulates endothelial cell-dependent growth support of human airway basal cells.Alveolar macrophage dynamics in murine lung regeneration.Reduced microRNA-503 expression augments lung fibroblast VEGF production in chronic obstructive pulmonary disease.Role of Inhaled Steroids in Vascular Airway Remodelling in Asthma and COPD.
P2860
Q28076273-0C9888C2-5E34-490F-AB49-486D48CC6038Q33323355-EB5275E8-04E7-483B-BB4C-4ADA3A2A2F4BQ33442068-B23B3462-5226-4FDE-8872-20379B810B44Q34053650-ECEDC0EC-5DA8-4018-A0F2-041485DBA7AEQ34328236-8F0C18F0-C157-414B-87B0-361F0C336C17Q34356136-87D46B29-9656-48D6-885D-46D09ECE0125Q34684230-2B5EAA61-745D-42B3-B333-72C7B3F73BB0Q34992988-641DB388-6941-474E-9B5F-3D85483199C3Q35005709-EEFA63DF-0DDC-4D29-A1A2-C3FDF81E7D9DQ35914781-F5D16F69-6E1B-413D-954D-BF94A1666F75Q36105708-8CA513FF-F050-43B2-9D51-471E6C5F1EB5Q36225770-8B30F252-7BCF-43F7-B075-2D8244188A4BQ36450466-7A139E8E-8A13-414B-AEC2-D8A0869635D3Q36470462-0078448C-C3A0-458E-B30B-D9897C85C3FAQ36480016-61EA76E6-4E2B-4792-8EE8-C99259347C60Q36511645-BBBD5110-3437-4150-93C5-A7882C916ADFQ36539037-273997E2-E7FB-4CBF-9612-247513E64331Q36625050-E6A6C93D-6DB6-4A51-8416-DAE3F52D3B19Q36779299-EDF5F4BD-2545-4DAC-9333-97C9A32C0271Q36946704-295A5E68-FF14-4246-92F9-AA82F30B5714Q37058368-595A9BFD-6EE4-4728-BDDA-988A3BADD3D1Q37071004-65AB4048-8DD7-48EE-9320-0DE0823031D6Q37082562-9B8FFD0A-D5E2-4204-8E2A-44AEFF0DFD5CQ37082574-FC1C54FE-0023-4B8C-8336-242455C44B37Q37156936-51D04090-0426-45C9-BAFA-D6AE57393A70Q37294009-63F56B81-03D5-42C2-8DC8-F7163AACA750Q37362620-5308D9A6-38BB-4265-B521-55560DBA59D6Q37445518-B3DCA8F4-C659-42EF-8AC2-5408A05D57F0Q37528259-EB8755BC-7C8C-41D7-A62A-66D128A69689Q37797577-C31A9D26-A1DC-4BE1-B919-3449E0148467Q38109057-A722816E-093B-4438-BDD4-096938A84AC4Q38111793-9AA84070-EDAC-47D0-971D-05836F7580CEQ38131445-D189BA71-E1DD-462D-8A8B-D9D5086DF530Q38591752-5E0486BE-E1D4-41E0-970B-C25541532B0BQ39172891-1055A9A5-7F78-436C-B33B-3B4C35A9890BQ39359815-ABF75C83-37AC-451D-9A06-464E3ADB70D5Q40016436-E407E2A5-D57D-48E2-81A5-7BE8DE8A3C49Q40881660-F94C8BA1-A21C-47DC-9F26-E803F33AF248Q41573646-A0B1E9B9-802F-41D1-8A69-9C2640A3F709Q42415224-E9024EB5-0B11-4229-BED3-8FDA1F8FFA03
P2860
Enhanced bronchial expression of vascular endothelial growth factor and receptors (Flk-1 and Flt-1) in patients with chronic obstructive pulmonary disease.
description
2005 nî lūn-bûn
@nan
2005 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Enhanced bronchial expression ...... obstructive pulmonary disease.
@ast
Enhanced bronchial expression ...... obstructive pulmonary disease.
@en
type
label
Enhanced bronchial expression ...... obstructive pulmonary disease.
@ast
Enhanced bronchial expression ...... obstructive pulmonary disease.
@en
prefLabel
Enhanced bronchial expression ...... obstructive pulmonary disease.
@ast
Enhanced bronchial expression ...... obstructive pulmonary disease.
@en
P2093
P2860
P356
P1433
P1476
Enhanced bronchial expression ...... obstructive pulmonary disease.
@en
P2093
Alagappan VK
Kranenburg AR
de Boer WI
P2860
P304
P356
10.1136/THX.2004.023986
P407
P577
2005-02-01T00:00:00Z